Disrupting the paradigm

As a woman-founded and led company with in-house manufacturing capabilities of its internally conceived portfolio of products, Femasys is well-positioned to deliver its solutions to the market with the achievement of global regulatory approvals.

Richard Spector

Chief Commercial Officer

Mr. Spector brings over 25 years of industry experience at both public and private biotechnology companies through various stages of commercialization. He has proven expertise in leading functional efforts in sales and marketing, key opinion leader strategy, product/brand development, reimbursement strategy, and strategic efforts. Most recently, he was chief commercial officer of Qlibrium (formally Cam-Med Inc.), a wearable device company. Prior to this, Mr. Spector was senior director, strategic alliances at Insulet Corporation and vice president of global sales and partner development at OvaScience, Inc. (acquired by Millendo Therapeutics, Inc.), where he was responsible for commercialization of their global fertility products. He was also in leadership positions at other Women’s Health companies, including NeoMatrix, Inc. (acquired by Halo Health Systems), Advanced Radiation Therapy, LLC (acquired by Best Medical International, Inc.) and Cytyc Surgical Products, LLC (acquired by Hologic, Inc.). Mr. Spector holds a BS in Business Administration and Marketing from California State University in Sacramento, CA.